CopyMark Law Group
4.9
Drawing for V-PUPSIT

USPTO serial 79356168

V-PUPSIT

Reviewed by CopyMark Law Group

Reg. 7362174Status 700Registered
Filing date
Status date
Registration date
Apr 23, 2024
Examiner
STEINPFAD, SARAH E
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with V-PUPSIT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Goods and services

ClassDescriptionStatusFirst use
005Aseptically manufactured pharmaceutical preparations and drugs for the prevention of infections, cancer, depression, heart diseases, vascular diseases, and intestinal disorder, lung and bronchial disfunction, liver disfunction, inflammation and inflammatory diseases, oral and laryngeal disease, optical and cranial disorders, arthritis, migraine, mucopolysaccharidosis, haemophilia, multiple sclerosis, osteoporosis, neuronal disorders, diabetes, erectile disfunction, infertility, crohn's disease, hereditary angioedema, thrombosis, encephalitis, diseases of the thyroid or parathyroid glands, metabolic diseases, muscular atrophy, disturbance of growth and anemia; pharmaceutical preparations to be taken orally and sterile, aseptic solutions and injection solutions for the prevention of infections, cancer, depression, heart diseases, vascular diseases, and intestinal disorder, lung and bronchial disfunction, liver disfunction, inflammation and inflammatory diseases, oral and laryngeal disease, optical and cranial disorders, arthritis, migraine, mucopolysaccharidosis, haemophilia, multiple sclerosis, osteoporosis, neuronal disorders, diabetes, erectile disfunction, infertility, crohn's disease, hereditary angioedema, thrombosis, encephalitis, diseases of the thyroid or parathyroid glands, metabolic diseases, muscular atrophy, disturbance of growth and anemia; eye drops, contact lens solutions; swabs for medical purposes; medical plasters; materials for medical dressings, namely, compresses, sterile pads, gauze, plastic films, gels, foams, hydrocolloids, alginates, pastes, granules and beadsACTIVE—
039Bottling services, namely, aseptic, sterile bottling of substancesACTIVE—
042Scientific research and development in the field of aseptic and sterile bottling services of substances and syringes for injections and instruments, injectors and associated packaging; engineering services, namely, chemical, physical and process engineering laboratory testing; testing of pharmaceuticals, namely, conducting of microbiological tests and procedures for othersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 9, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 23, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 23, 2024FIMPFINAL DISPOSITION PROCESSED—
Jul 24, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 23, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 23, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 6, 2024GPNXNOTIFICATION PROCESSED BY IB—
Feb 6, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 6, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 17, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 17, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 17, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 4, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 20, 2023DOCKASSIGNED TO EXAMINER—
Nov 15, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 14, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 14, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 12, 2023RFNTREFUSAL PROCESSED BY IB—
May 17, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 17, 2023RFRRREFUSAL PROCESSED BY MPU—
Mar 29, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 28, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 28, 2023DOCKASSIGNED TO EXAMINER—
Dec 6, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 2, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 1, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance